Adjuvant therapy for Stage IA uterine clear cell carcinoma with no myometrial invasion: a critical review of literature

Desteli G. A., DOĞAN N. U., Gursu T., Ayhan A.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.37, sa.1, ss.17-21, 2016 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 37 Sayı: 1
  • Basım Tarihi: 2016
  • Dergi Adı: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.17-21
  • Anahtar Kelimeler: Uterine clear cell carcinoma, Adjuvant treatment, High grade endometrial cancer, GENE-EXPRESSION PROFILES, ENDOMETRIAL CARCINOMA, ADENOCARCINOMA, BRACHYTHERAPY, RADIOTHERAPY, MANAGEMENT, PROGNOSIS, CANCERS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Uterine clear cell carcinoma (UCC) is an aggressive variant of endometrial cancer. Comprehensive surgical staging is strongly recommended for these patients as an upstaging to Stage 3-4 occur in 35-50% of patients. Stage 1A (no myometrial invasion) according to FIGO 1988 staging system are seen very rarely in patients. In most of the studies, regarding adjuvant treatment, clear cell carcinoma were all evaluated with papillary serous carcinoma (PSC). Studies on clear cell histology are low in number and also a limited number of patients were included. Proportion of patients with complete surgical staging, number of lymph nodes excised, and rate of omentectomy were all heterogenous and were not presented uniformly in studies. There is no concensus regarding adjuvant treatment for Stage 1A patients. Some authors suggest only close observation. Vaginal brachytherapy is also strongly recommended in some studies of this review. Multi-institutional studies with homogenous patient characteristics with homogeneous surgery is warranted.